Celularity (CELU) Research & Development (2020 - 2026)
Celularity (CELU) recorded Research & Development of $2.03 million in Q2 2026, down 39.5% from $3.35 million a year earlier and down 32.3% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Celularity's Research & Development came in at $12.97 million as of Jun 30, 2026, down 12.5% year-over-year; for FY2025, it came in at $15.03 million, down 13.6% from FY2024.
- Annual Research & Development has declined for four straight years, with a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $17.39 million in FY2024 (-42.9%), $30.47 million in FY2023 (-61.1%), $78.36 million in FY2022 (-11.3%) and $88.35 million in FY2021 (+67.6%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2023.
- On a year-over-year basis, Research & Development has declined for three consecutive quarters, with an average decline of 18.1% over the last seven quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 111.9% in Q3 2021, against a decline of 74.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.99 million (Q1 2026), $3.35 million (Q4 2025) and $4.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Celularity | 30.75 Mn | 23.50 Mn | 3.09 Mn | 2.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.99 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | 5.18 Mn |
| Jun 30, 2023 | 8.60 Mn |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 20.35 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 21.67 Mn |
| Dec 31, 2021 | 24.69 Mn |
| Sep 30, 2021 | 23.77 Mn |
API Access
Celularity Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();